跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 91 条关于
“CDKN2A”
全部
91
临床试验
27
药物
38
机构
0
资讯
26
去年
Cyclacel Completes Enrollment in Fadraciclib Trial for Tumors with CDKN2A/B Abnormalities
去年
Cellular Senescence Gene Signature Reveals New Biomarkers for Idiopathic Pulmonary Fibrosis
上个月
Next-Generation 3D Cancer Models Reveal Clinically Relevant Gene Dependencies Missed by Traditional Cell Lines
去年
Novel Synthetic Lethal Approaches Show Promise in Targeting MTAP and SMARCA4 Mutations in Lung Cancer
上个月
ctDNA Clearance and MRD May Identify NSCLC Patients Who Benefit Most from Perioperative Nivolumab
去年
Cost and Implementation Barriers Challenge Adoption of Novel mUC Therapies, ASCO GU Studies Show
去年
Bluebird Bio's Skysona Linked to Blood Cancers in Pediatric Patients
去年
Tempus Presents New Breast Cancer Research at SABCS 2024, Highlighting AI-Driven Precision Medicine
3个月前
Bap1-mediated deubiquitination governs Treg immune tolerance and anti-tumor immunity via ferroptosis control
去年
Amivantamab Shows Promise in Colorectal Cancer as Phase 3 Trials Launch Following Encouraging Phase 1b/2 Results
第 1 页,共 3 页
上一页
下一页